Models of LRRK2-Associated Parkinson’s Disease
- 29 March 2017
- book chapter
- review article
- Published by Springer Science and Business Media LLC
- Vol. 14, 163-191
- https://doi.org/10.1007/978-3-319-49969-7_9
Abstract
Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are the most common genetic causes of Parkinson’s disease (PD) and also one of the strongest genetic risk factors in sporadic PD. The LRRK2 protein contains a GTPase and a kinase domain and several protein-protein interaction domains. Both in vitro and in vivo assays in different model systems have provided tremendous insights into the molecular mechanisms underlying LRRK2-induced dopaminergic neurodegeneration. Among all the model systems, animal models are crucial tools to study the pathogenesis of human disease. How do the animal models recapitulate LRRK2-induced dopaminergic neuronal loss in human PD? To answer this question, this review focuses on the discussion of the animal models of LRRK2-associated PD including genetic- and viral-based models.Keywords
This publication has 87 references indexed in Scilit:
- Leucine-rich repeat kinase 2 deficiency is protective in rhabdomyolysis-induced kidney injuryHuman Molecular Genetics, 2015
- LRRK2 Controls an EndoA Phosphorylation Cycle in Synaptic EndocytosisNeuron, 2012
- Neurodegenerative phenotypes in an A53T-synuclein transgenic mouse model are independent of LRRK2Human Molecular Genetics, 2012
- (G2019S) LRRK2 activates MKK4-JNK pathway and causes degeneration of SN dopaminergic neurons in a transgenic mouse model of PDCell Death & Differentiation, 2012
- Translation Initiator EIF4G1 Mutations in Familial Parkinson DiseaseAmerican Journal of Human Genetics, 2011
- The Parkinson's disease protein LRRK2 impairs proteasome substrate clearance without affecting proteasome catalytic activityCell Death & Disease, 2011
- LRRK2 protein levels are determined by kinase function and are crucial for kidney and lung homeostasis in miceHuman Molecular Genetics, 2011
- Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's diseaseNature Medicine, 2010
- Enhanced Striatal Dopamine Transmission and Motor Performance with LRRK2 Overexpression in Mice Is Eliminated by Familial Parkinson's Disease Mutation G2019SJournal of Neuroscience, 2010
- Mutant LRRK2R1441G BAC transgenic mice recapitulate cardinal features of Parkinson's diseaseNature Neuroscience, 2009